Company intelligence / Profile preview

OriGen Biomedical

Austin, Texas, United Statesorigen.com ↗

Ownership: Private
Employees: ~180
Development stage: Commercial

Overview

OriGen Biomedical manufactures and globally distributes FDA-cleared and CE-marked cryopreservation bags, cell culture bags, bioreactors, DMSO solutions, and related accessories. Their products are widely used to support the manufacture of advanced therapies such as CAR-T cells and stem cells. The company has a strong reputation for quality—holding ISO 13485/MDSAP certifications—and custom product development capabilities. No clinical trial results apply as they do not develop drugs.

Therapeutic areas: OncologyRare Diseases
Modalities: Device (cryopreservation bags, cell culture bags, bioreactors)Biologic (as used in cell and gene therapy workflows)Accessory sets for fluid transfer in cell processing
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on OriGen Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OriGen Biomedical.

Explore the full profile